Delhi, India

Binay Kumar Bhuwania

This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Coral Drugs Pvt. Ltd.. Active years: 2019-2020.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Location History:

  • New Delhi, IN (2019)
  • Delhi, IN (2020)

Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Binay Kumar Bhuwania

Introduction

Binay Kumar Bhuwania is a notable inventor based in Delhi, India. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of corticosteroids and glucocorticoid steroids. With a total of two patents to his name, Bhuwania's work reflects his dedication to advancing medical science.

Latest Patents

His latest patents include a process for the preparation of corticosteroids. This invention discloses a method for creating pregnadiene derivatives, which are crucial in the development of various steroid medications. The patent details the formula I, where each substituent can be independently selected from hydrogen or various alkyl chains. Additionally, he has developed a process for the preparation of glucocorticoid steroids, focusing on 16, 17-acetals of pregnane derivatives, which also follows a specific formula for its components.

Career Highlights

Binay Kumar Bhuwania is currently associated with Coral Drugs Pvt. Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in enhancing the efficiency of steroid preparation processes, contributing to the availability of essential medications.

Collaborations

He collaborates with talented individuals such as Vinayak Tripathi and Rajesh Kumar, who share his vision for advancing pharmaceutical research and development.

Conclusion

Binay Kumar Bhuwania's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…